Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26FV7R3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,972
Award facts
- Contract value 100% obligated
- $21,972.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,972.09 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of January 14, 2026, and performance taking place in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine headaches. This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that regularly fulfills federal medical procurement requirements through competitive awards. The company's contract portfolio with the Defense Logistics Agency demonstrates extensive capability in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military treatment facilities and other federal healthcare systems. As a child entity of Cencora, Inc., AmerisourceBergen participates in the strategic pharmaceutical supply chain supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations.
Quick answers
Who was awarded contract SPE2DR26FV7R3?
SPE2DR26FV7R3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FV7R3 worth?
The government has obligated $21,972 on SPE2DR26FV7R3.
Is contract SPE2DR26FV7R3 an order under another contract?
Yes. SPE2DR26FV7R3 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7R3 competed?
The extent of competition for SPE2DR26FV7R3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award